Bibliography
- Wang GS. Medical uses of mylabris in ancient China and recent studies. J Ethnopharmacol 1989;26:147-62
- Yell JA, Buge SM, Dean D. Cantharidin-induced acantholysis in Darier‘s disease: dose acantholysis initiate dyskeratosis. Br J Dermatol 1994;131:40-7
- McCluskey A, Ackland SP, Gardiner E, The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design? Anticancer Drug Des 2001;16:291-303
- Fillmore K, Bagatell K, Dugan BS. Phospholipids and cantharidin induced acantholysis in human epidermis. J Invest Dermatol 1966;47:606-7
- McCluskey A, Alistair TRS, Jennette AS. Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies. J Med Chem 2002;45:1151-75
- Andrabi S, Gjoerup OV, Kean JA, Protein phosphatase 2A regulates life and death decisions via Akt in a context-dependent manner. Proc Natl Acad Sci USA 2007;104:19011-16
- Janssens V, Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 2001;353:417-39
- Goldberg Y. Protein phosphatase 2A: who shall regulate the regulator? Biochem Pharmacol 1999;57:321-8
- Virshup DM. Protein phosphatase 2A: a panoply of enzymes. Curr Opin Cell Biol 2000;12:180-5
- Strack S, Wadzinski BE, Ebner FF. Localization of the calcium/calmodulin-dependent protein phosphatase, calcineurin, in the hindbrain and spinal cord of the rat. J Comput Neurol 1996;375:66-76
- Bertini I, Calderone V, Fragai M, Structural basis of serine/threonine phosphatase inhibition by the archetypal small molecules cantharidin and norcantharidin. J Med Chem 2009;52:4838-43
- Tocci MJ, Matkovich DA, Collier KA, The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol 1989;143:718-26
- Flanagan WM, Corthesy B, Bram RJ, The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature 1991;352:803-7
- Tsao L, Neville C, Musaro A, Revisiting calcineurin and human heart failure. Nat Med 2000;6:2-3
- Wang KR, Wang YC, Sun ZQ, Biological effect of sodium norcantharidate on several mammalian cell lines. 4th Int Gongr Cell Biol 1988;76
- Liao HF, Su SL, Chen YN, Norcantharidin preferentially induces apoptosis in human leukemic Jurkat cells without affecting viability of normal blood mononuclear cells. Food Chem Toxicol 2007;45:1678-87
- Liu XH, Blazsek I, Comisso M, Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cells. Eur J Cancer 1995;31:953-63
- Deng LP, Liu FM, Wang HY. 1,3-Dipolar cycloaddition reaction of novel 5,6-dehydronorcantharidin derivafives of substituted aromatic amines withpotential antitumor activities. J Heterocyel Chem 2005;42:13-l8
- Padmavathi V, Venugopal RK, Padmaja A, Unusual reaction of chloramine-T with araldoximes. Org Chem 2003;68:1567-70
- Purevsuren G, Koblicova Z, Trojanek J. Cantharidinimide, a novel substance from Mylabris mongolica dokht. Cesko- Slovenska pharmacie 1987;36:32-4
- Lee JY, Chung YJ, Bae YS, Synthesis of hexapeptide and tetrapeptide analogs of the immunomodulating peptides. J Chem Soc Perkin Trans 1998;2:359-66
- Tomita K, Sugai S, Kobayashi T, Studies on isoxazoles.VIII. Versatile synthesis and chemical properties of 3-chloroisoxazolium chlorides. Chem Pharm Bull (Tokyo) 1979;27:2398-404
- Berson JA, Reynolds RD, Jones WM. The stereochemistry and mechamsm of the Diels-Alder reaction. An“intenal”mechanism for the interconveresion of endo-exo isomers. J Am Chem Soc 1956;78:6094-7
- McCluskey A, Keane MA, Walkom C C, The first two cantharidin analogues displaying PP1 selectivity. Bioorg Med Chem Lett 2002;12:391-3
- McCluskey A, Taylor C, Quinn RJ, Inhibition of protein phosphatase 2A by cantharidin analogues. Bioorg Med Chem Lett 1996;6:1025-8
- McCluskey A, Keane MA, Mudgee LM, Norcantharimide analogues possessing terminal phosphate esters and their anti-cancer activity. Bioorg Med Chem 2000;35:957-64
- McCluskey A, Bowyer MC, Collins E, Anhydride modified cantharidin analogues: synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity. Bioorg Med Chem Lett 2000;10:1687-90
- McCluskey A, Walkom C, Bowyer MC, Cantharidimides, a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A. Bioorg Med Chem Lett 2001;11:2941-6
- Sakoff JA, Ackland SP, Baldwin ML, Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues. Invest New Drugs 2002;21:1-11
- McCluskey A, Ackland SP, Bowyer MC, Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines. Bioorg Chem 2003;31:68-79
- Hart ME, Chamberlin AR, Walkom C, Modified norcantharidins synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activity. Bioorg Med Chem Lett 2004;14:1969-73
- Enz A, Zenke G, Pombo-Villar E. 7-Oxa [2.2.1]bicycloheptane-2,3-dicarboxylic acid derivatives as phosphatase inhibitors. Bioorg Med Chem Lett 1997;7:2513-18
- Soseoka M, Baba Y, Kobayashi S, Structure-activity relationship of cantharidin derivatives to protein phosphatases 1, 2A1, and 2B. Bioorg Med Chem Lett 1997;7:1833-6
- Tatlock JH, Linton MA, Hou XJ, Structure-based design of novel calcineurin (PP2B) inhibitors. Bioorg Med Chem Lett 1997;7:1007-12
- Chang CC, Liu DZ, Lin SY, Liposome encapsulation reduces cantharidin toxicity. Food Chem Toxicol 2008;46:3116-21
- Hill TA, Stewart SG, Ackland SP, Norcantharimides, synthesis and anticancer activity: Synthesis of new norcantharidin analogues and their anticancer evaluation. Bioorg Med Chem 2007;15:6126-34
- Nakatani T, Jinpo K, Noda N. Cantharimide dimers from the chinese blister beetle, Mylabris phalerate Pallas.. Chem Pharm Bull (Tokyo) 2007;55:92-4
- Deng LP. Norcantharidin dimer derivate as well as synthetic method and application thereof. CN101768173A; 2010
- Zhang XN, Hu ZH, Zhou Y, Norcantharidin analogues and synthesis. CN101367850A; 2009. Available from: http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=9&adjacent=true&locale=en_EP&FT=D&date=20090218&CC=CN&NR=101367850A&KC=A [Last accessed 13 Oct]
- Tan ZY, Zhang H, Zen S, Antineoplastic active canthardin derivative and method for preparing same. CN101161654A; 2008
- Deng YH, Hong WW, Zhang L, Water soluble cantharidin and/or norcantharidin chitosan derivative and preparation method thereof. CN101735335A; 2010
- Yan JW, Di CS, Du CD. Norcantharidin esterified derivatives and preparation method thereof. CN101575343A; 2009
- Zhou Y, Chen DF, Li YQ, Amino acid norcantharidin acid imide derivative with optical activity and preparation method thereof. CN101270122A; 2008
- Chen YC, Chang SC, Wu MS, Norcantharidin reduced cyclins and cytokines production in human peripheral blood mononuclear cells. Life Sci 2009;84:218-26
- Tang YM, Zhang JY. Preparation of immunoliposome of CD19 monoclonal antibody and application. CN101612126A; 2009
- Deng LP. Norcantharidin derivative and activity testing method and application thereof. CN101863909A; 2010
- Stewart SG, Hill TA, Gilbert J, Synthesis and biological evaluation of norcantharidin analogues: Towards PP1 selectivity. Bioorg Med Chem 2007;15:7301-10
- Hill TA, Stewart TG, Sauer B, Heterocyclic substituted cantharidin and norcantharidin analogues synthesis, protein phosphatase (1 and 2A) inhibition, and anticancer activity. Bioorg Med Chem Lett 2007;17:3392-7
- McCluskey A, Sakoff A. Small molecule inhibitors of serine/threonine protein phosphatases. Mini Rev Med Chem 2001;1:43-5
- McCluskey A, Sim ATR, Sakoff JA. Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies. J Med Chem 2002;45:1151-75
- Sheppeck JE, Gauss CM, Chamberlin AR. Inhibition of the Ser-Thr phosphatases PP1 and PP2A by naturally occurring toxins. Bioorg Med Chem 1997;5:1739-50
- Hart ME, Chamberlin AR, Walklom C, Modified norcantharidins; synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activity. Bioorg Med Chem Lett 2004;14:1969-73
- McCluskey A, Keane MA, Walkom C, The first two cantharidin analogues displaying PP1 selectivity. Bioorg Med Chem Lett 2002;12:391-3
- McCluskey A, Bowyer MC, Walkom C, Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A. Bioorg Med Chem Lett 2001;11:2941-6
- Tatlock JH, Linton MA, Hou XJ, Structure-based design of novel calcineurin (PP2B) inhibitors. Bioorg Med Chem Lett 1997;7:1007-12
- McCluskey A, Taylor C, Quinn RJ, Inhibition of protein phosphatase 2A by cantharidin analogues. Bioorg Med Chem Lett 1996;6:1025-8
- Deng LP. Pyrazolo N-substituted dehydronorcantharidin imide derivative as well as synthesis method, activity test method and application thereof. CN101812066A; 2010